Breast Cancer Clinical Trial

Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy

Summary

Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is safe and effective in patients with early stage breast cancer resected by lumpectomy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Be a Tis, T1, N0, M0 AJC Classification
Have negative surgical margins (> or = 2 mm) after final surgery
Should have adequate skin spacing between balloon surface and surface the skin (> 7 mm)*
Patients with infiltrating lobular histologies should have breast MRI scanning as part of the initial staging to verify localized T1, or Tis disease
Multifocal findings (define as 2 or more breast quadrants) on MRI scanning should be further evaluated by ultrasound and, if necessary biopsy, to exclude multiquadrant disease.

Exclusion Criteria:

Be pregnant or breast-feeding
Have collagen-vascular disease
Inadequate surgical margins (< 2 mm)
Patients with malignant/suspicious calcifications

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

291

Study ID:

NCT01185145

Recruitment Status:

Active, not recruiting

Sponsor:

Rocky Mountain Cancer Centers

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Rocky Mountain Cancer Centers - Aurora
Aurora Colorado, 80012, United States
Rocky Mountain Cancer Centers - Boulder
Boulder Colorado, 80303, United States
Rocky Mountain Cancer Centers - Midtown
Denver Colorado, 80128, United States
Rocky Mountain Cancer Centers - Littleton
Littleton Colorado, 80120, United States
Rocky Mountain Cancer Centers - Sky Ridge
Lone Tree Colorado, 80124, United States
Rocky Mountain Cancer Centers - Thornton
Thornton Colorado, 80260, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

291

Study ID:

NCT01185145

Recruitment Status:

Active, not recruiting

Sponsor:


Rocky Mountain Cancer Centers

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.